Intra-Cellular Therapies Inc (ITCI)
72.60
-0.52
(-0.71%)
USD |
NASDAQ |
Apr 25, 10:19
Intra-Cellular Therapies Market Cap: 7.028B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 7.079B |
| April 23, 2024 | 7.165B |
| April 22, 2024 | 7.216B |
| April 19, 2024 | 7.006B |
| April 18, 2024 | 6.970B |
| April 17, 2024 | 7.424B |
| April 16, 2024 | 7.729B |
| April 15, 2024 | 6.269B |
| April 12, 2024 | 6.378B |
| April 11, 2024 | 6.580B |
| April 10, 2024 | 6.513B |
| April 09, 2024 | 6.643B |
| April 08, 2024 | 6.554B |
| April 05, 2024 | 6.625B |
| April 04, 2024 | 6.506B |
| April 03, 2024 | 6.517B |
| April 02, 2024 | 6.454B |
| April 01, 2024 | 6.609B |
| March 28, 2024 | 6.699B |
| March 27, 2024 | 6.749B |
| March 26, 2024 | 6.518B |
| March 25, 2024 | 6.580B |
| March 22, 2024 | 6.682B |
| March 21, 2024 | 6.620B |
| March 20, 2024 | 6.506B |
| Date | Value |
|---|---|
| March 19, 2024 | 6.336B |
| March 18, 2024 | 6.328B |
| March 15, 2024 | 6.271B |
| March 14, 2024 | 6.251B |
| March 13, 2024 | 6.313B |
| March 12, 2024 | 6.231B |
| March 11, 2024 | 6.334B |
| March 08, 2024 | 6.533B |
| March 07, 2024 | 6.459B |
| March 06, 2024 | 6.392B |
| March 05, 2024 | 6.449B |
| March 04, 2024 | 6.508B |
| March 01, 2024 | 6.921B |
| February 29, 2024 | 6.730B |
| February 28, 2024 | 6.886B |
| February 27, 2024 | 7.057B |
| February 26, 2024 | 6.928B |
| February 23, 2024 | 6.792B |
| February 22, 2024 | 6.963B |
| February 21, 2024 | 7.094B |
| February 20, 2024 | 7.135B |
| February 16, 2024 | 7.291B |
| February 15, 2024 | 7.218B |
| February 14, 2024 | 6.938B |
| February 13, 2024 | 6.785B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
401.10M
Minimum
Oct 01 2019
7.729B
Maximum
Apr 16 2024
3.501B
Average
3.353B
Median
Market Cap Benchmarks
| Insmed Inc | 3.705B |
| Fate Therapeutics Inc | 394.97M |
| ADMA Biologics Inc | 1.450B |
| Jaguar Health Inc | 45.75M |
| Rhythm Pharmaceuticals Inc | 2.314B |
Market Cap Related Metrics
| PS Ratio | 15.06 |
| Price to Book Value | 11.88 |
| Price | 72.60 |
| Earnings Yield | -2.01% |